Patents Assigned to Source Precision Medicine, Inc. d/b/d Source MDX
  • Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects
    Publication number: 20110070582
    Abstract: A method is provided in various embodiments for determining a profile data set for predicting the response top immunotherapy and or survivability of a subject with melanoma based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification under measurement conditions that are substantially repeatable for measuring the amount of RNA corresponding to at least 2, 3 or 4 constituents according to the gene models shown in Tables 2-3, 4-6 and 9.
    Type: Application
    Filed: June 2, 2010
    Publication date: March 24, 2011
    Applicant: Source Precision Medicine, Inc. d/b/d Source MDX
    Inventors: Danute M. Bankaitis-Davis, Lisa Siconolfi, Kathleen Storm, Karl Wassmann